ID   SCUB3_HUMAN             Reviewed;         993 AA.
AC   Q8IX30; A8K5A3; Q5CZB3; Q86UZ9; Q8NAU9;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   07-APR-2021, entry version 157.
DE   RecName: Full=Signal peptide, CUB and EGF-like domain-containing protein 3;
DE   Flags: Precursor;
GN   Name=SCUBE3 {ECO:0000312|HGNC:HGNC:13655};
GN   Synonyms=CEGF3 {ECO:0000312|EMBL:AAN76808.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305, ECO:0000312|EMBL:AAU08347.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBUNIT, SUBCELLULAR LOCATION,
RP   TISSUE SPECIFICITY, AND GLYCOSYLATION.
RC   TISSUE=Osteoblast {ECO:0000269|PubMed:15234972};
RX   PubMed=15234972; DOI=10.1074/jbc.m405912200;
RA   Wu B.-T., Su Y.-H., Tsai M.-T., Wasserman S.M., Topper J.N., Yang R.-B.;
RT   "A novel secreted, cell-surface glycoprotein containing multiple epidermal
RT   growth factor-like repeats and one CUB domain is highly expressed in
RT   primary osteoblasts and bones.";
RL   J. Biol. Chem. 279:37485-37490(2004).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:AAN76808.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Pfarr N., Bahr A., Cichutek A., Loebbert R., Zabel B.U., Schmidt E.R.,
RA   Hankeln T., Winterpacht A.;
RT   "Novel human gene family (CEGF) encoding mosaic proteins with EGF-like,
RT   STT2R and a CUB module: cloning and expression analysis.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAC03798.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 45-993 (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4] {ECO:0000305, ECO:0000312|EMBL:Z97832}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAN76808.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAH52263.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Pancreas {ECO:0000312|EMBL:AAH52263.2};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 158-993 (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   FUNCTION, INTERACTION WITH TGFBR2, TISSUE SPECIFICITY, AND PROTEOLYTIC
RP   CLEAVAGE BY MMP2 AND MMP9.
RX   PubMed=21441952; DOI=10.1038/onc.2011.85;
RA   Wu Y.Y., Peck K., Chang Y.L., Pan S.H., Cheng Y.F., Lin J.C., Yang R.B.,
RA   Hong T.M., Yang P.C.;
RT   "SCUBE3 is an endogenous TGF-beta receptor ligand and regulates the
RT   epithelial-mesenchymal transition in lung cancer.";
RL   Oncogene 30:3682-3693(2011).
CC   -!- FUNCTION: Binds to TGFBR2 and activates TGFB signaling. In lung cancer
CC       cells, could serve as an endogenous autocrine and paracrine ligand of
CC       TGFBR2, which could regulate TGFBR2 signaling and hence modulate
CC       epithelial-mesenchymal transition and cancer progression.
CC       {ECO:0000269|PubMed:21441952}.
CC   -!- SUBUNIT: Forms homooligomers and heterooligomers with SCUBE1. Interacts
CC       with TGFBR2 through the CUB domain; this interaction does not affect
CC       TGFB1-binding to TGFBR2. {ECO:0000269|PubMed:15234972,
CC       ECO:0000269|PubMed:21441952}.
CC   -!- INTERACTION:
CC       Q8IX30; P08253: MMP2; NbExp=2; IntAct=EBI-4479975, EBI-1033518;
CC       Q8IX30; P14780: MMP9; NbExp=2; IntAct=EBI-4479975, EBI-1382326;
CC       Q8IX30; P37173: TGFBR2; NbExp=6; IntAct=EBI-4479975, EBI-296151;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15234972}. Cell
CC       surface {ECO:0000269|PubMed:15234972}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:15234972, ECO:0000269|PubMed:15489334,
CC       ECO:0000269|Ref.2};
CC         IsoId=Q8IX30-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334};
CC         IsoId=Q8IX30-2; Sequence=VSP_052167;
CC   -!- TISSUE SPECIFICITY: Highly expressed in osteoblasts. In normal lung,
CC       mainly expressed in bronchial epithelial cells. Tends to be up-
CC       regulated in lung cancer cells. {ECO:0000269|PubMed:15234972,
CC       ECO:0000269|PubMed:21441952}.
CC   -!- PTM: N-glycosylated. {ECO:0000269|PubMed:15234972}.
CC   -!- PTM: Proteolytic cleavage produces a CUB-containing C-terminal fragment
CC       that retains the ability to bind to TGFBR2. This reaction is catalyzed
CC       in vitro by MMP2 and, to a lesser extent, by MMP9.
CC       {ECO:0000269|PubMed:21441952}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC03798.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY639608; AAU08347.1; -; mRNA.
DR   EMBL; AF452494; AAN76808.1; -; mRNA.
DR   EMBL; AK092062; BAC03798.1; ALT_INIT; mRNA.
DR   EMBL; AK291218; BAF83907.1; -; mRNA.
DR   EMBL; Z97832; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471081; EAX03812.1; -; Genomic_DNA.
DR   EMBL; BC052263; AAH52263.2; -; mRNA.
DR   EMBL; CR936607; CAI56752.1; -; mRNA.
DR   CCDS; CCDS4800.1; -. [Q8IX30-1]
DR   RefSeq; NP_001290065.1; NM_001303136.1.
DR   RefSeq; NP_689966.2; NM_152753.3. [Q8IX30-1]
DR   RefSeq; XP_005249000.1; XM_005248943.1. [Q8IX30-2]
DR   SMR; Q8IX30; -.
DR   BioGRID; 128812; 1.
DR   IntAct; Q8IX30; 3.
DR   STRING; 9606.ENSP00000274938; -.
DR   GlyGen; Q8IX30; 5 sites.
DR   iPTMnet; Q8IX30; -.
DR   PhosphoSitePlus; Q8IX30; -.
DR   BioMuta; SCUBE3; -.
DR   DMDM; 74762488; -.
DR   jPOST; Q8IX30; -.
DR   MassIVE; Q8IX30; -.
DR   PaxDb; Q8IX30; -.
DR   PeptideAtlas; Q8IX30; -.
DR   PRIDE; Q8IX30; -.
DR   ProteomicsDB; 70970; -. [Q8IX30-1]
DR   ProteomicsDB; 70971; -. [Q8IX30-2]
DR   Antibodypedia; 29465; 179 antibodies.
DR   DNASU; 222663; -.
DR   Ensembl; ENST00000274938; ENSP00000274938; ENSG00000146197. [Q8IX30-1]
DR   GeneID; 222663; -.
DR   KEGG; hsa:222663; -.
DR   UCSC; uc003okf.2; human. [Q8IX30-1]
DR   CTD; 222663; -.
DR   DisGeNET; 222663; -.
DR   GeneCards; SCUBE3; -.
DR   HGNC; HGNC:13655; SCUBE3.
DR   HPA; ENSG00000146197; Tissue enhanced (thyroid).
DR   MIM; 614708; gene.
DR   neXtProt; NX_Q8IX30; -.
DR   OpenTargets; ENSG00000146197; -.
DR   PharmGKB; PA134977856; -.
DR   VEuPathDB; HostDB:ENSG00000146197.8; -.
DR   eggNOG; KOG1217; Eukaryota.
DR   GeneTree; ENSGT00940000153185; -.
DR   HOGENOM; CLU_013079_0_0_1; -.
DR   InParanoid; Q8IX30; -.
DR   OMA; NCGPGRE; -.
DR   OrthoDB; 73164at2759; -.
DR   PhylomeDB; Q8IX30; -.
DR   TreeFam; TF351672; -.
DR   PathwayCommons; Q8IX30; -.
DR   Reactome; R-HSA-1474228; Degradation of the extracellular matrix.
DR   BioGRID-ORCS; 222663; 4 hits in 934 CRISPR screens.
DR   ChiTaRS; SCUBE3; human.
DR   GenomeRNAi; 222663; -.
DR   Pharos; Q8IX30; Tbio.
DR   PRO; PR:Q8IX30; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q8IX30; protein.
DR   Bgee; ENSG00000146197; Expressed in metanephros and 151 other tissues.
DR   Genevisible; Q8IX30; HS.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0022617; P:extracellular matrix disassembly; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   CDD; cd00041; CUB; 1.
DR   Gene3D; 2.60.120.290; -; 1.
DR   InterPro; IPR026823; cEGF.
DR   InterPro; IPR000859; CUB_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR024731; EGF_dom.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR035914; Sperma_CUB_dom_sf.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   Pfam; PF12662; cEGF; 1.
DR   Pfam; PF00431; CUB; 1.
DR   Pfam; PF12947; EGF_3; 1.
DR   Pfam; PF07645; EGF_CA; 2.
DR   Pfam; PF07699; Ephrin_rec_like; 3.
DR   SMART; SM00042; CUB; 1.
DR   SMART; SM00181; EGF; 10.
DR   SMART; SM00179; EGF_CA; 7.
DR   SUPFAM; SSF49854; SSF49854; 1.
DR   SUPFAM; SSF57184; SSF57184; 3.
DR   PROSITE; PS00010; ASX_HYDROXYL; 6.
DR   PROSITE; PS01180; CUB; 1.
DR   PROSITE; PS01186; EGF_2; 7.
DR   PROSITE; PS50026; EGF_3; 6.
DR   PROSITE; PS01187; EGF_CA; 6.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..20
FT                   /evidence="ECO:0000255"
FT   CHAIN           21..993
FT                   /note="Signal peptide, CUB and EGF-like domain-containing
FT                   protein 3"
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000250616"
FT   DOMAIN          29..69
FT                   /note="EGF-like 1; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          70..111
FT                   /note="EGF-like 2; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          112..148
FT                   /note="EGF-like 3; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          157..198
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          199..237
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          238..276
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          277..317
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          318..356
FT                   /note="EGF-like 8; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          357..398
FT                   /note="EGF-like 9; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          804..916
FT                   /note="CUB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00059"
FT   CARBOHYD        417
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        464
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        685
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        756
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        785
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        33..46
FT                   /evidence="ECO:0000255"
FT   DISULFID        40..55
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..68
FT                   /evidence="ECO:0000255"
FT   DISULFID        74..86
FT                   /evidence="ECO:0000255"
FT   DISULFID        82..95
FT                   /evidence="ECO:0000255"
FT   DISULFID        97..110
FT                   /evidence="ECO:0000255"
FT   DISULFID        116..127
FT                   /evidence="ECO:0000255"
FT   DISULFID        123..136
FT                   /evidence="ECO:0000255"
FT   DISULFID        161..172
FT                   /evidence="ECO:0000255"
FT   DISULFID        168..182
FT                   /evidence="ECO:0000255"
FT   DISULFID        184..197
FT                   /evidence="ECO:0000255"
FT   DISULFID        201..212
FT                   /evidence="ECO:0000255"
FT   DISULFID        208..221
FT                   /evidence="ECO:0000255"
FT   DISULFID        223..236
FT                   /evidence="ECO:0000255"
FT   DISULFID        240..251
FT                   /evidence="ECO:0000255"
FT   DISULFID        247..260
FT                   /evidence="ECO:0000255"
FT   DISULFID        262..275
FT                   /evidence="ECO:0000255"
FT   DISULFID        281..292
FT                   /evidence="ECO:0000255"
FT   DISULFID        288..301
FT                   /evidence="ECO:0000255"
FT   DISULFID        303..316
FT                   /evidence="ECO:0000255"
FT   DISULFID        322..332
FT                   /evidence="ECO:0000255"
FT   DISULFID        328..341
FT                   /evidence="ECO:0000255"
FT   DISULFID        343..355
FT                   /evidence="ECO:0000255"
FT   DISULFID        361..372
FT                   /evidence="ECO:0000255"
FT   DISULFID        368..381
FT                   /evidence="ECO:0000255"
FT   DISULFID        383..397
FT                   /evidence="ECO:0000255"
FT   DISULFID        804..830
FT                   /evidence="ECO:0000255"
FT   DISULFID        857..878
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         237
FT                   /note="I -> IGERRLEQHIPTQAVSN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:17974005"
FT                   /id="VSP_052167"
FT   VARIANT         410
FT                   /note="S -> L (in dbSNP:rs3800381)"
FT                   /id="VAR_048994"
FT   CONFLICT        157
FT                   /note="Missing (in Ref. 6; AAH52263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        256
FT                   /note="T -> I (in Ref. 6; AAH52263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        483..484
FT                   /note="AS -> SP (in Ref. 3; BAC03798)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        635
FT                   /note="K -> E (in Ref. 7; CAI56752)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        856
FT                   /note="E -> G (in Ref. 7; CAI56752)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   993 AA;  109282 MW;  19BBE0E5627EEAF4 CRC64;
     MGSGRVPGLC LLVLLVHARA AQYSKAAQDV DECVEGTDNC HIDAICQNTP RSYKCICKSG
     YTGDGKHCKD VDECEREDNA GCVHDCVNIP GNYRCTCYDG FHLAHDGHNC LDVDECAEGN
     GGCQQSCVNM MGSYECHCRE GFFLSDNQHT CIQRPEEGMN CMNKNHGCAH ICRETPKGGI
     ACECRPGFEL TKNQRDCKLT CNYGNGGCQH TCDDTEQGPR CGCHIKFVLH TDGKTCIETC
     AVNNGGCDSK CHDAATGVHC TCPVGFMLQP DRKTCKDIDE CRLNNGGCDH ICRNTVGSFE
     CSCKKGYKLL INERNCQDID ECSFDRTCDH ICVNTPGSFQ CLCHRGYLLY GITHCGDVDE
     CSINRGGCRF GCINTPGSYQ CTCPAGQGRL HWNGKDCTEP LKCQGSPGAS KAMLSCNRSG
     KKDTCALTCP SRARFLPESE NGFTVSCGTP SPRAAPARAG HNGNSTNSNH CHEAAVLSIK
     QRASFKIKDA KCRLHLRNKG KTEEAGRITG PGGAPCSECQ VTFIHLKCDS SRKGKGRRAR
     TPPGKEVTRL TLELEAEVRA EETTASCGLP CLRQRMERRL KGSLKMLRKS INQDRFLLRL
     AGLDYELAHK PGLVAGERAE PMESCRPGQH RAGTKCVSCP QGTYYHGQTE QCVPCPAGTF
     QEREGQLSCD LCPGSDAHGP LGATNVTTCA GQCPPGQHSV DGFKPCQPCP RGTYQPEAGR
     TLCFPCGGGL TTKHEGAISF QDCDTKVQCS PGHYYNTSIH RCIRCAMGSY QPDFRQNFCS
     RCPGNTSTDF DGSTSVAQCK NRQCGGELGE FTGYIESPNY PGNYPAGVEC IWNINPPPKR
     KILIVVPEIF LPSEDECGDV LVMRKNSSPS SITTYETCQT YERPIAFTAR SRKLWINFKT
     SEANSARGFQ IPYVTYDEDY EQLVEDIVRD GRLYASENHQ EILKDKKLIK AFFEVLAHPQ
     NYFKYTEKHK EMLPKSFIKL LRSKVSSFLR PYK
//
